TELUS Health Solutions Inc. acquired Canadian operations of ZRx Prescriber Technology from Zoommed Inc. (TSXV:ZMD) for CAD 6.8 million on September 3, 2014. TELUS Health will pay CAD 5 million at closing, CAD 0.5 million in adjustments regarding deferred revenues and CAD 1.3 million contingent payment subject to certain conditions. The transaction includes transferring affected ZoomMed Canadian employees to TELUS Health and will give TELUS sole ownership of ZRx Prescriber and its IP in Canada. The TSX Venture Exchange has granted a conditional approval for the transaction but remains subject to its final approval. ZoomMed will use the proceeds of this transaction to reimburse its actual debenture and for working capital in order to invest in the marketing and deployment of the ZRx Prescriber technology worldwide.


TELUS Health Solutions Inc. completed the acquisition of Canadian operations of ZRx Prescriber Technology from Zoommed Inc. (TSXV:ZMD) on September 3, 2014.